Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: Case report and literature review

Acta Haematologica

Volumn 122, Issue 4, 2009, Pages 221-222

  Sobas, Marta A ^a   Pérez Encinas, Manuel M ^a   Rabuñal Martinez, María J ^a   Quinteiro García, Celsa ^b   Bello López, José L ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b Fundacion Publica Galega de Medicina Xenomica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANAGRELIDE; ENOXAPARIN;

ADULT; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FIRST TRIMESTER PREGNANCY; GENE MUTATION; HUMAN; PREGNANCY OUTCOME; PRIORITY JOURNAL; THROMBOCYTHEMIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AMINO ACID SUBSTITUTION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFANT, NEWBORN; JANUS KINASE 2; POINT MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; QUINAZOLINES; THROMBOCYTHEMIA, ESSENTIAL;

EID: 70350525103     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253030     Document Type: Article

References (6)

1. Harrison C: Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol 2005; 129: 293-306.
2. Finazzi G, Barbui T: Evidence and expertise in the management of polycythemia vera and essential thrombocythemia. Leukemia 2008; 22: 1494-1502.
3. Barbui T, Finazzi G: Myeloproliferative disease in pregnancy and other management issues. Hematology Am Soc Hematol Educ Program 2006; 246-252.
4. Alkindi S, Dennison D, Pathare A: Successful outcome with anagrelide in pregnancy. Ann Hematol 2005; 84: 758-759.
5. Wright CA, Tefferi AA: A single institutional experience with 43 pregnancies in essential thrombocythemia. Eur J Haematol 2001; 66: 152-159.
6. Doubek M, Brychtova Y, Doubek R, Janku P, Mayer J: Anagrelide therapy in pregnancy: report of a case of essential thrombocythemia. Ann Hematol 2004; 83: 726-727.